ClinicalTrials.govpublic full text
Radiolabeled SMT-487 (Yttrium Y 90-DOTA-tyr3-octreotide) in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer
breast cancer, lung cancer, stage iv breast cancer, recurrent breast cancer, recurrent small cell lung cancer, male breast cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 904823
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.